Genix Pharmaceuticals Corporation
GENPF · OTC
10/31/2024 | 10/31/2023 | 10/31/2022 | 10/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$73 | -$4,396 | -$1,074 | -$1,653 |
| Dep. & Amort. | $1 | $547 | $564 | $537 |
| Deferred Tax | $0 | $0 | $28 | $0 |
| Stock-Based Comp. | $27 | $59 | $259 | $809 |
| Change in WC | $30 | $56 | -$6 | -$124 |
| Other Non-Cash | -$172 | $3,512 | $9 | $2 |
| Operating Cash Flow | -$187 | -$221 | -$220 | -$428 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$3 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | -$3 | $0 |
| Investing Cash Flow | $0 | $0 | -$3 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $187 | $282 | $148 | -$14 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$59 | -$55 | -$115 |
| Financing Cash Flow | $187 | $223 | $93 | -$129 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$0 | $2 | -$130 | -$558 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $12 | $9 | $139 | $697 |
| End Cash | $11 | $12 | $9 | $139 |
| Free Cash Flow | -$187 | -$221 | -$223 | -$428 |